2.23
-0.09 (-3.88%)
| Previous Close | 2.32 |
| Open | 2.31 |
| Volume | 29,290 |
| Avg. Volume (3M) | 67,514 |
| Market Cap | 102,471,848 |
| Price / Earnings (TTM) | 8.26 |
| Price / Sales | 0.670 |
| Price / Book | 0.510 |
| 52 Weeks Range |
| Profit Margin | -28.39% |
| Operating Margin (TTM) | -86.82% |
| Diluted EPS (TTM) | -0.440 |
| Quarterly Revenue Growth (YOY) | -23.00% |
| Quarterly Earnings Growth (YOY) | -85.30% |
| Total Debt/Equity (MRQ) | 53.16% |
| Current Ratio (MRQ) | 1.73 |
| Operating Cash Flow (TTM) | -66.93 M |
| Levered Free Cash Flow (TTM) | -31.19 M |
| Return on Assets (TTM) | -7.09% |
| Return on Equity (TTM) | -17.03% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Bullish | |
| Stock | Intercure Ltd. | Mixed | Mixed |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 4.0 |
| Average | 0.81 |
|
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 30.20% |
| % Held by Institutions | 5.35% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |